MK-0767, a novel dual PPARα/γ agonist, displays robust antihyperglycemic and hypolipidemic activities
- 28 May 2004
- journal article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 318 (2), 323-328
- https://doi.org/10.1016/j.bbrc.2004.04.032
Abstract
No abstract availableKeywords
This publication has 14 references indexed in Scilit:
- Minireview: Adiposity, Inflammation, and AtherogenesisEndocrinology, 2003
- Distinct Properties and Advantages of a Novel Peroxisome Proliferator-Activated Protein γ Selective ModulatorMolecular Endocrinology, 2003
- Diabetes, Plasma Insulin, and Cardiovascular DiseaseArchives of Internal Medicine, 2002
- The Mechanisms of Action of PPARsAnnual Review of Medicine, 2002
- (−)3-[4-[2-(Phenoxazin-10-yl)ethoxy]phenyl]-2-ethoxypropanoic Acid [(−)DRF 2725]: A Dual PPAR Agonist with Potent Antihyperglycemic and Lipid Modulating ActivityJournal of Medicinal Chemistry, 2001
- Peroxisome Proliferator-activated Receptor α Activators Improve Insulin Sensitivity and Reduce AdiposityOnline Journal of Public Health Informatics, 2000
- (3-Substituted benzyl)thiazolidine-2,4-diones as structurally new antihyperglycemic agentsBioorganic & Medicinal Chemistry Letters, 1999
- A novel insulin sensitizer acts as a coligand for peroxisome proliferator-activated receptor-alpha (PPAR-alpha) and PPAR-gamma: effect of PPAR-alpha activation on abnormal lipid metabolism in liver of Zucker fatty rats.Diabetes, 1998
- Nuclear Receptors Have Distinct Affinities for Coactivators: Characterization by Fluorescence Resonance Energy TransferMolecular Endocrinology, 1998
- Alterations in Lipoprotein Metabolism in Peroxisome Proliferator-activated Receptor α-deficient MiceOnline Journal of Public Health Informatics, 1997